TRDA
#3379
Entrada Therapeutics, Inc. - Common Stock
7.2 7 USD
+0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.86%
Monthly Change
+25.78%
6 month change
-38.34%
Year Change
+4.30%
Previous Close
7.0 0
Open
7.2 7
Low
7.2 7
High
7.2 7
Volume
34
Financials
- Market Capitalization 283.07 M
- Employee 152
- Founded 2016
- CEO N/A
- Website www.entradatx.com
- Headquarter Delaware, United States
- FIGI BBG00MTSMC16
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.96
Price to sales ratio
16.73
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3365 |  AVXL Anavex Life Sciences Corp. - Common Stock | 3.13 USD | -3.40% | -1.57% | +22.27% | -65.98% | 290.06 M USD | ||
| 3378 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 2.05 USD | +3.54% | +1.99% | +4.06% | +79.82% | 283.47 M USD | ||
| 3383 |  SRZN Surrozen, Inc. - Common Stock | 24.01 USD | +1.27% | +1.18% | +22.63% | +107.16% | 282.20 M USD | ||
| 3399 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 3.88 USD | -0.26% | -1.77% | -15.65% | +116.76% | 278.09 M USD |
Frequently asked questions about Entrada Therapeutics, Inc. Common Stock
What is the Entrada Therapeutics, Inc. Common Stock stock price today?
The current price of Entrada Therapeutics, Inc. Common Stock (TRDA) is 7.27. Over the past 24 hours, the stock has changed by +3.86%. Follow the TRDA chart for real-time price dynamics.
What is the stock ticker of Entrada Therapeutics, Inc. Common Stock?
Entrada Therapeutics, Inc. Common Stock trades under the ticker TRDA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Entrada Therapeutics, Inc. Common Stock stock going up?
TRDA has changed by -4.84% over the last week, +25.78% over the last month, and +4.30% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Entrada Therapeutics, Inc. Common Stock?
Entrada Therapeutics, Inc. Common Stock currently has a market capitalization of 283.07 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Entrada Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Entrada Therapeutics, Inc. Common Stock reported earnings of -1.01 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Entrada Therapeutics, Inc. Common Stock revenue for the last quarter?
Entrada Therapeutics, Inc. Common Stock reported quarterly revenue of 898 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Entrada Therapeutics, Inc. Common Stock net income for the last quarter?
Entrada Therapeutics, Inc. Common Stock reported net income of -42.76 M for the last quarter. The previous quarter showed -39.72 M, which means net income changed by -7.67%.
How many employees does Entrada Therapeutics, Inc. Common Stock have?
As of the latest available data, Entrada Therapeutics, Inc. Common Stock has 152 employees. Workforce size can provide additional context about the company's scale and operations.
What is Entrada Therapeutics, Inc. Common Stock EBITDA?
Entrada Therapeutics, Inc. Common Stock EBITDA is -44.61 M, and its EBITDA margin is -4 968.04%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Entrada Therapeutics, Inc. Common Stock stock?
You can buy Entrada Therapeutics, Inc. Common Stock (TRDA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Entrada Therapeutics, Inc. Common Stock stock?
Investing in Entrada Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TRDA chart and related analysis on metatrader.com as part of your research.